AGA Family of Websites: Gastro.org
Search

Explore the evaluation and management of seronegative enteropathies and IBD in elderly patients

Gastroenterology jumpstarts the year with two new AGA Clinical Practice Updates.
Jan_ImageChallenge_CGH (1)
Jan_ImageChallenge_CGH (1)

AGA has released two new clinical practice updates in the January issue of Gastroenterology providing best practice advice in the evaluation and management of seronegative enteropathies and inflammatory bowel disease in elderly patients.  

In the AGA Clinical Practice Update on the Evaluation and Management of Seronegative Enteropathies: Expert Review, the authors provide guidance to aid in your diagnosis and management of patients with suspected celiac disease who have received negative results for serologic tests. Accurate diagnoses of seronegative enteropathies are often perceived as a challenge due to misinterpretation of histologic findings.

In the short video below, lead author Maureen Leonard, MD, MMSc, from Massachusetts General Hospital, highlights the best practice advice statements to address key issues in clinical management of these patients:

One out of every 160 elderly individuals are affected by inflammatory bowel disease (IBD) with the prevalence of the disease rising by 5.2% every year. The AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review was developed to provide the best practices to assess diagnosis, general principle treatments and health maintenance of older patients experiencing difficulties with IBD.

Charles N. Bernstein, MD, from the University of Manitoba, gives insight into the development of this clinical practice update in the video below.

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.

Stay in the know with AGA

Members receive our weekly newsletter, AGA eDigest, which is packed with clinical education updates, career development opportunities, member news and more.

Stay connected. Stay informed. Stay ahead.

X